Viatris Inc (VTRS)
11.62
+0.16
(+1.44%)
USD |
NASDAQ |
Nov 05, 16:00
11.60
-0.02
(-0.17%)
After-Hours: 18:22
Viatris Max Drawdown (5Y): 82.15% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 82.15% |
September 30, 2024 | 82.15% |
August 31, 2024 | 82.15% |
July 31, 2024 | 82.15% |
June 30, 2024 | 82.15% |
May 31, 2024 | 82.15% |
April 30, 2024 | 82.15% |
March 31, 2024 | 82.15% |
February 29, 2024 | 82.15% |
January 31, 2024 | 82.15% |
December 31, 2023 | 82.15% |
November 30, 2023 | 82.15% |
October 31, 2023 | 82.15% |
September 30, 2023 | 82.15% |
August 31, 2023 | 82.15% |
July 31, 2023 | 82.15% |
June 30, 2023 | 82.15% |
May 31, 2023 | 82.15% |
April 30, 2023 | 82.15% |
March 31, 2023 | 82.15% |
February 28, 2023 | 82.15% |
January 31, 2023 | 82.15% |
December 31, 2022 | 82.15% |
November 30, 2022 | 82.15% |
October 31, 2022 | 82.15% |
Date | Value |
---|---|
September 30, 2022 | 82.15% |
August 31, 2022 | 82.15% |
July 31, 2022 | 82.15% |
June 30, 2022 | 82.15% |
May 31, 2022 | 82.15% |
April 30, 2022 | 82.15% |
March 31, 2022 | 82.15% |
February 28, 2022 | 82.15% |
January 31, 2022 | 82.15% |
December 31, 2021 | 82.15% |
November 30, 2021 | 82.15% |
October 31, 2021 | 82.15% |
September 30, 2021 | 82.15% |
August 31, 2021 | 82.15% |
July 31, 2021 | 82.15% |
June 30, 2021 | 82.15% |
May 31, 2021 | 82.15% |
April 30, 2021 | 82.15% |
March 31, 2021 | 82.15% |
February 28, 2021 | 82.15% |
January 31, 2021 | 82.15% |
December 31, 2020 | 82.15% |
November 30, 2020 | 82.15% |
October 31, 2020 | 82.15% |
September 30, 2020 | 82.15% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
77.91%
Minimum
Nov 2019
82.15%
Maximum
Mar 2020
81.87%
Average
82.15%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Lexicon Pharmaceuticals Inc | 94.56% |
Eli Lilly and Co | 22.48% |
Amgen Inc | 24.86% |
Gilead Sciences Inc | 41.71% |
Perspective Therapeutics Inc | 91.70% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -21.30 |
Beta (5Y) | 0.9318 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 35.74% |
Historical Sharpe Ratio (5Y) | -0.2596 |
Historical Sortino (5Y) | -0.362 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 17.26% |